关闭
 
读者在线:用户名 密码
首页 期刊简介 投稿须知 期刊目录 专家风采 编委会 特邀顾问 联系我们 移动出版
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5



刊物信息

期刊名称:药物分析杂志
主管单位:中国科学技术协会
主办单位:中国药学会
承办:中国食品药品检定研究院
主编:金少鸿
地址:北京天坛西里2号
邮政编码:100050
电话:010-67012819,67058427
电子邮箱:ywfx@nifdc.org.cn
国际标准刊号:ISSN 0254-1793
国内统一刊号:CN 11-2224/R
邮发代号:2-237
 

访问统计
您是第  1 0 5 3 2 9 9 5 位浏览者
您当前的位置:首页 >> 正文

蛋白质及纤维素衍生物手性固定相分离盐酸昂丹司琼对映体___

Enantiomers separation of ondansetron hydrochloride using proteinate- and amylase-based chiral stationary phase

分类号:
出版年·卷·期(页码):2009,29 (6):0-0
DOI: 10.16155/j.0254-1793.2017.01.01
-----摘要:-------------------------------------------------------------------------------------------

摘要 目的:研究盐酸昂丹司琼对映体在纤维素衍生物及蛋白质固定相上的保留行为,优化色谱条件,并测定盐酸左昂丹司琼(R)中右旋异构体(S)的含量。方法:Chiralcel OJ和Ultron ES-OVM为固定相时,流动相分别为正己烷-乙醇-二乙胺(60∶40∶0.1)和10 mmol•L-1甲酸铵缓冲液(pH 4.8)-乙腈(95∶5) 检测波长分别为245 nm和249 nm,并考察了影响分离的因素。结果:盐酸昂丹司琼对映体在上述2种手性固定相均达到基线分离。昂丹司琼对映体的检测限分别为3 ng(Chiralcel OJ)和6 ng(Ultron ES-OVM)。结论:所建立的方法均可方便地分离盐酸昂丹司琼对映体并测定盐酸左昂丹司琼原料和注射液中右旋异构体的含量。
Key words:

-----英文摘要:---------------------------------------------------------------------------------------

Abstract Objective:HPLC methods were developed for the separation of the enantiomers of ondansetron hydrochloride using derivatized cellulose and protein chiral stationary phases and the methodology for detection of impurity of S-ondansetron in R-ondansetron injection and raw material is established.Methods:The separation were performed on Chiralcel OJ and Ultron ES-OVM with the mobile phase being hexane-alcohol-diethylamine (60∶40∶0.1) and 10 mmol•L-1 ammonium formate buffer solution (pH 4.8)-acetonitrile(95∶5),respectively.The detective wavelength was 245 nm and 249 nm,respectively.Several parameters on separation were studied.Results:Baseline separation was easily obtained in all cases. LOD of ondansetron enantiomers were 3 ng(Chiralcel OJ)and 6 ng(Ultron ES-OVM ).Conclusion:All the methods developed in this study can be used for separation and quantitation of enantiomers of ondansetron hydrochloride conveniently.

-----参考文献:---------------------------------------------------------------------------------------
1Patil PA,Kothekar MA.Development of safer molecules through chirality.Indian J Med Sci,2006,60(10):427
2Kelly JW,He L,Stewart JT.High-performance liquid chromatographic separation of ondansetron enantiomers in serum using a cellulose-derivatized stationary phase and solid-phase extraction. J Chromatogr,1993,622(2):291
3Liu J,Stewart JT.High-performance liquid chromatographic analysis of ondansetron enantiomers in human serum using a reversed-phase cellulose-based chiral stationary phase and solid-phase extraction.J Chromatogr B Biomed Sci Appl,1997,694(1):179
4Hermansson J,Grahn A.Optimization of the separation of enantiomers of basic drugs retention mechanisms and dynamic modification of the chiral bonding properties on an α1-acid glycoprotein column .J Chromatogr A,1995,694(1):57
5Hermansson J.Enantiomeric separation of drugs and related compounds based on their interaction with α1-acid glycoprotein.Trends Anal Chem,1989,8:251
6Gyimesi-Forras K,Szasz G,Gergely A,et al.Optical resolution of a series of potential cholecystokinin antagonist 4(3H)-quinazolone derivatives by chiral liquid chromatography on alphal acid glycoprotein stationary phase. J Chromatogr Sci, 2000,38(10):430

欢迎阅读《药物分析杂志》!您是该文第 2442位读者!

药物分析杂志 © 2009
地址:北京天坛西里2号 邮政编码:100050; 电子邮件:ywfx@nicpbp.org.cn